Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ma, X. Guo (Beijing, China). The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus. Eur Respir J 2011; 38: Suppl. 55, 2272

Member's Comments

No comment yet.

Related content which might interest you: The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence Source: Sleep and Breathing Conference 2021 Year: 2021 Prevalence of obstructive sleep apnoea in men with type 2 diabetes Source: Eur Respir J 2005; 26: Suppl. 49, 567s Year: 2005 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Oxygen desaturation is associated with diabetes mellitus in patients with obstructive sleep apnoea Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011 Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: 156-160 Year: 2003 Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007 Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 Screening of sleep apnea-hypopnea syndrome in patients with type 2 diabetes Source: Annual Congress 2012 - Technology, screening and questionnaires in OSA Year: 2012 Insulin resistance and insulin sensitivity in patients with sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Insulin resistance in obstructive sleep apnea patients Source: Annual Congress 2010 - Pulmonary circulation III Year: 2010 Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011 Cystatin C as a marker of cardiovascular diseases in patients with obstructive sleep apnea (OSA) with concomitant diabetes mellitus type 2 (DM2) Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 The association of obstructive sleep apnea with insulin resistance in obese Egyptians Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases Year: 2019